"Barclays kept its Equal Weight rating on Five Below while lifting its price target to $211 from $193. The firm acknowledges that the dollar-store segment continues to benefit from favorable external trends, including value-conscious consumer behavior, but notes that market expectations already appear elevated."
"Canaccord's Buy-rated thesis on Ulta Beauty is more assertive. The firm raised its target to $799 from $674, citing continued sales growth, margin expansion, and earnings gains as the company regains market share and begins expanding internationally."
"Five Below's strong recent execution: the company posted a 14.3% comparable sales increase in Q3 and raised its full-year guidance. Barclays appears to be flagging that much of the good news may already be reflected in the share price."
Barclays raised Five Below's price target to $211 while maintaining an Equal Weight rating, suggesting the stock already reflects positive expectations despite strong Q3 performance. Canaccord Genuity increased targets for both Ulta Beauty to $799 and Nature's Sunshine Products to $29, expressing greater confidence in these companies' growth trajectories. Ulta Beauty's case centers on market share recovery and international expansion potential, while Nature's Sunshine benefits from digital momentum and Asia-Pacific growth. The analyst moves reflect conviction in underlying business momentum, though with different urgency levels regarding upside potential and current valuation levels.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]